Johnson & Johnson invested $6m to help radiotherapy equipment developer Reflexion Medical close out its Pfizer-backed series B round at $52m.
US-based medical equipment producer Reflexion Medical closed a $52m series B round yesterday following a $6m investment by healthcare company Johnson & Johnson, provided by its Johnson & Johnson Innovation – JJDC unit.
The funding followed a $46m first tranche in April this year featuring Pfizer Venture Investments, the corporate venturing vehicle of pharmaceutical firm Pfizer, as well as family investment fund KCK Group, which led the round, and venture capital firms Sofinnova Partners and Venrock.
Reflexion Medical is…